Novo Nordisk, based in Denmark, is a company dedicated to the health care and a world leader in diabetes care. Novo Nordisk also has a strong presence in areas such as haemostasis management, growth and hormone replacement therapy. The company manufactures and markets pharmaceutical products and services that make significant difference to patients, doctors and health professionals. Novo Nordisk employs approximately 38,000 people in 81 countries. Present in Brazil since the early 1990, Novo Nordisk has consolidated its presence in the country in 2002 when it bought the laboratory Biobras. Reaffirming the importance and the company's commitment to the country in April 2007, Novo Nordisk launched in Montes Claros - MG, the largest manufacturer of insulin products in Latin America, with investments of more than US$ 200 million.
Headquarters
Avenida C 1413, Distrito Industrial
Montes Claros; Minas Gerais;
Postal Code: 39404004
Contact Details: Purchase the Novo Nordisk Producao Farmaceutica do Brasil Ltda. report to view the information.
Website: http://www.novonordisk.com.br
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service